SPIA
TSVT

Steward Partners Investment Advisory’s 2seventy bio TSVT Stock Holding History

Steward Partners Investment Advisory’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-239
Closed -$1.18K – 4243
2025
Q1 		$1.18K Sell
239
-300
-56% -$953 ﹤0.01% 3743
2024
Q4 		$1.58K Hold
539
– – ﹤0.01% 3686
2024
Q3 		$2.54K Hold
539
– – ﹤0.01% 3394
2024
Q2 		$2.08K Hold
539
– – ﹤0.01% 3280
2024
Q1 		$2.88K Buy
539
+133
+33% +$626 ﹤0.01% 3211
2023
Q4 		$1.73K Buy
406
+300
+283% +$922 ﹤0.01% 3228
2023
Q3 		$416 Hold
106
– – ﹤0.01% 3255
2023
Q2 		$1.07K Hold
106
– – ﹤0.01% 3125
2023
Q1 		$1.08K Hold
106
– – ﹤0.01% 3113
2022
Q4 		$993 Hold
106
– – ﹤0.01% 3122
2022
Q3 		$2K Hold
106
– – ﹤0.01% 3069
2022
Q2 		$1K Hold
106
– – ﹤0.01% 3169
2022
Q1 		$2K Hold
106
– – ﹤0.01% 3117
2021
Q4 		$3K Buy
+106
New +$3.31K ﹤0.01% 2969

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Steward Partners Investment Advisory's TSVT Position: Q2 2025 in Review

Steward Partners Investment Advisory sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 239 shares — an estimated $1.18K sold.

Steward Partners Investment Advisory first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $3K in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Steward Partners Investment Advisory reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 239 2seventy bio shares in Q2 2025, an estimated $1.18K.
  • Steward Partners Investment Advisory first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Steward Partners Investment Advisory's 2seventy bio position peaked at $3K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2025, filed 12 Aug 2025.